Psychedelic Business Spotlight: November 26
This week in psychedelic business news: Compass Pathways files another patent; Seelos Therapeutics raises big money; Cybin makes psychedelic therapy more accessible in NYC.
ketamine
PharmaTher Believes Ketamine Could Treat This Rare Neurological Condition
The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS.
Manhattan Hospital Partners with Cybin to Provide Psychedelic Therapies to Marginalized Communities
“It’s time for psychedelic medicine to climb down from the ivory tower and into the community,” says Cybin Chief Clinical Officer Dr. Alex Belser.
Psychedelic Mom and Therapist Explains How Giving Birth Was Like a ‘Wild Acid Trip’
Kate Kincaid, who specializes in psychedelic integration and ketamine-assisted therapy, appears on the premiere of our new series “Spotlight in Focus” to share parallels between labor and tripping on psychedelics.
Parents Are Very Open to Ketamine Therapy for Kids, Study Finds
“As parents maintain decision-making capacity of their child’s medical care, parental consent is a key factor in the adoption of new treatments for adolescents,” study authors explain.
FDA Backs Ketamine to Treat This Rare and Debilitating Pain Syndrome
Food and Drug Administration grants psychedelic biotechnology company PharmaTher orphan drug designation for ketamine to treat complex regional pain syndrome.
Psychedelic Business Spotlight: October 8, 2021
This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative care program; and PharmaTher tests ketamine to treat Parkinson’s Disease.
Psychedelics Helped Me Heal From Sexual Trauma and Research Shows I’m Not Alone
Reprocessing sexual trauma is a difficult task, but psychedelics are presenting themselves as a powerful tool to help survivors.
The Legal Status of Psychedelics Around the World
In Brazil, there have been no instances of an individual being punished for the consumption, cultivation, or possession of magic mushrooms.
Ketamine One Partners with OVR Technology to Provide Scent-Enabled VR Psychedelic Experiences
Take a whiff of the latest development in virtual reality technology available to further immerse patients in psychedelic-assisted therapy.
End of content
End of content